EGFR signaling pathway as therapeutic target in human cancers

E Levantini, G Maroni, M Del Re, DG Tenen - Seminars in cancer biology, 2022 - Elsevier
Abstract Epidermal Growth Factor Receptor (EGFR) enacts major roles in the maintenance
of epithelial tissues. However, when EGFR signaling is altered, it becomes the grand …

Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge

D Sturm, S Bender, DTW Jones, P Lichter, J Grill… - Nature Reviews …, 2014 - nature.com
We have extended our understanding of the molecular biology that underlies adult
glioblastoma over many years. By contrast, high-grade gliomas in children and adolescents …

Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression

AT Yeo, S Rawal, B Delcuze, A Christofides… - Nature …, 2022 - nature.com
Glioblastoma (GBM) is an incurable primary malignant brain cancer hallmarked with a
substantial protumorigenic immune component. Knowledge of the GBM immune …

Human glioblastoma arises from subventricular zone cells with low-level driver mutations

JH Lee, JE Lee, JY Kahng, SH Kim, JS Park, SJ Yoon… - Nature, 2018 - nature.com
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall
survival of fifteen months,. Identifying the cell of origin that harbours mutations that drive …

Multiplexed profiling of single extracellular vesicles

K Lee, K Fraser, B Ghaddar, K Yang, E Kim, L Balaj… - ACS …, 2018 - ACS Publications
Extracellular vesicles (EV) are a family of cell-originating, membrane-enveloped
nanoparticles with diverse biological function, diagnostic potential, and therapeutic …

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

H Shao, J Chung, L Balaj, A Charest, DD Bigner… - Nature medicine, 2012 - nature.com
Glioblastomas shed large quantities of small, membrane-bound microvesicles into the
circulation. Although these hold promise as potential biomarkers of therapeutic response …

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

FB Furnari, TF Cloughesy, WK Cavenee… - Nature Reviews …, 2015 - nature.com
As tumours evolve, the daughter cells of the initiating cell often become molecularly
heterogeneous and develop different functional properties and therapeutic vulnerabilities. In …

Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma

T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito… - Cancer cell, 2014 - cell.com
To understand the relationships between the non-GCIMP glioblastoma (GBM) subgroups,
we performed mathematical modeling to predict the temporal sequence of driver events …

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice

D Friedmann-Morvinski, EA Bushong, E Ke, Y Soda… - Science, 2012 - science.org
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain
tumor in humans. Here we show that gliomas can originate from differentiated cells in the …

Targeting autophagy to sensitive glioma to temozolomide treatment

Y Yan, Z Xu, S Dai, L Qian, L Sun, Z Gong - Journal of experimental & …, 2016 - Springer
Temozolomide (TMZ), an alkylating agent, is widely used for treating primary and recurrent
high-grade gliomas. However, the efficacy of TMZ is often limited by the development of …